Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

Today, 6:53 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19)

ABVC

8 minute read

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

By Shanthi Rexaline

Today, 6:53 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

ABSI

14 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 6:53 PM

On Monday morning, 207 companies hit new 52-week lows.

ACAD

1 minute read

Earnings

Return on Capital Employed Overview: Ardelyx

By Benzinga Insights

Today, 6:53 PM

Pulled from Benzinga Pro data Ardelyx (NASDAQ:ARDX) reported Q2 sales of $1.31 million. Earnings fell to a loss of $44.83 million, resulting in a 40.08% decrease from last quarter.

ARDX

1 minute read

Ardelyx: Q2 Earnings Insights

By Benzinga Insights

Today, 6:53 PM

Shares of Ardelyx (NASDAQ:ARDX) moved higher by 2.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 60.71% over the past year to ($0.45), which missed the estimate of ($0.36).

ARDX

1 minute read

Ardelyx Q2 EPS $(0.45) Down From $(0.28) YoY, Sales $1.31M Down From $1.84M YoY

By Benzinga Newsdesk

Today, 6:53 PM

Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.45) per share. This is a 60.71 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.31 million in sales this

ARDX

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 6:53 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

8 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 6:53 PM

Monday morning saw 115 companies set new 52-week lows.

AGCB

5 minute read

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

By Shanthi Rexaline

Today, 6:53 PM

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

ABBV

9 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 6:53 PM

Before 10 a.m. ET Friday, 117 stocks made new 52-week lows.

ABCL